Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 7 minute read Pharma Industry News Why Blue Jet Healthcare (NSE: BLUEJET) is spending Rs 1,000cr on Vizag while its stock hovers near IPO price Blue Jet Healthcare breaks ground on Rs 1,000 crore Vizag API plant as BLUEJET stock trades near lows. What the Rs 2,300 crore expansion means for investors. bySrinathMarch 1, 2026